Wednesday, November 18, 2026 Evidence-led medical research news
The First Cohort
Medical research, with the receipts

alzheimers

28 stories tagged "alzheimers"

Investigations

PubPeer Comments Ran a Median of 10 Months Ahead of Retractions. Cassava Answered Its Critics With a Lawsuit.

Retracted papers drew comments on PubPeer a median of 10 months before journals pulled them. The Cassava file shows what can happen to the people doing the commenting, and how much of the institutional record never becomes public.

Brain & Aging

Motor Neurons Carrying Alzheimer's Mutations Fumbled the Signal to Healthy Muscle, With No Brain Attached

Healthy muscle, mutant motor neurons, no brain or spinal cord: the nerve-to-muscle signal still faltered, and two standard Alzheimer's drugs failed to rescue it in the PSEN1 line.

Brain & Aging

In Older Brains Carrying More Tau, Deep-Sleep Waves Travel Less and Overnight Memory Slips

Older adults with more frontal tau had more deep-sleep waves that fired alone instead of sweeping across the brain, and they recalled fewer word pairs the next morning. Which comes first is still an open question.

Brain & Aging

Alzheimer's "DNA Repair" Drug Rests on Three Mice per Group and No Memory Test

An experimental compound sold as a new Alzheimer's drug was injected into three male mice per group, and none of them took a memory test. Human dosing so far has lasted at most a week, in men aged 19 to 45.

Brain & Aging

If You Feel Fine, the Scientists Studying This Alzheimer's Blood Marker Say Skip the Test

Cognitively unimpaired adults with the highest p-tau217 levels had an estimated 38 percent five-year risk of cognitive impairment. The researchers won't recommend testing people without symptoms. Lilly's prevention trial used the marker to screen 63,124.

Brain & Aging

The Omega-3 Trial Headlined as a Brain-Health Bust Was Built to Measure Spinal Fluid

Two years of high-dose DHA reached the spinal fluid of older adults exactly as planned. The memory scores behind the "no benefit" headlines were an exploratory outcome, and 38 percent of volunteers dropped out.

Brain & Aging

Your Aging Brain May Be Swapping Details for Wisdom. Nobody Has Measured the Wisdom.

Three neuroscientists argue that midlife forgetting is the brain shifting toward meaning. Older studies document the lost detail and the confident false memories that come with it. The promised wisdom has never been measured.

Brain & Aging

Clear Most of the Brain's Microglia and Alzheimer's Mice Sleep Two Hours More, Plaque Load Unchanged

In amyloid mice, plaque piled up while lost sleep held flat, and the sleep came back when most microglia were cleared. That is an awkward result for an industry selling plaque removal.

Brain & Aging

Drugs Aimed at This Week's Brain-Inflammation Target Have Already Failed in Patients

AstraZeneca and Pfizer each took a P2X7 blocker into rheumatoid arthritis trials, and neither beat placebo. A Birmingham lab now says the same receptor could tame inflammation in Alzheimer's and Parkinson's.

Brain & Aging

A Gut Molecule Tied to Diabetes and Clogged Arteries Now Tracks With Alzheimer's Decline

In 1,196 cognitively healthy adults, the people with the most of one gut-made molecule in their blood declined fastest, and a genetic variant carried by about 43 percent was linked to higher levels.

Brain & Aging

In Lab Tests, the Alzheimer's Fragment Labeled 'Non-Amyloidogenic' Builds Amyloid Faster Than Amyloid Beta

For decades the alpha pathway was billed as the safe way to cut the Alzheimer's precursor protein. Its leftover fragment, p3, builds fibrils in less than half the time amyloid beta needs in lab tests, forms ring-shaped pores, and turns up in plaques where a common antibody stain can't tell the two a

Brain & Aging

Alzheimer's Drugmakers Bet on Raising This Brain Sugar. Glucosamine May Be Overfeeding It.

In UF Health records, people with mild cognitive impairment who took the joint supplement were 25 percent more likely to slip into dementia. Glucosamine feeds the same brain chemistry a failed Alzheimer's drug was built to raise.

Brain & Aging

A Salsa Class, a Grocery List, and 38 Check-Ins Beat Health Advice on Memory by 55%

Across 11 Latin American countries, a coached program of exercise, an adapted MIND diet, and cognitive training improved older adults' thinking 55 percent more than periodic health advice, with no infusion chair and no $26,500-a-year drug.

Brain & Aging

For Twenty Years, Women Were Warned That Estrogen Raised Their Dementia Risk. Stanford's Autopsies Point the Other Way.

A randomized federal trial spent two decades warning that hormone therapy raised older women's dementia risk. A Stanford autopsy study just found the opposite association. The catch: both studied women who started the drug far too late to settle it.

Brain & Aging

The Fat Molecule That Rides From Your Waistline to Your Brain, and Feeds Alzheimer's Once It Gets There

In obese mice, a membrane fat called phosphatidylethanolamine packed into tiny vesicles, rode to the brain, and sabotaged the immune cells that clear amyloid. An investigational drug reversed it, in mice.

Brain & Aging

Anti-Tau Alzheimer's Drugs Keep Hitting Their Target and Missing the Disease

Tau is the new headliner at the Alzheimer's conference, but the anti-tau antibodies keep proving they bind the protein while doing nothing for patients. The clearest win so far is a blood test.

Brain & Aging

A Brain Full of Plaques and a Mind That Held: The Cells That May Explain Alzheimer's Resilient Third

About a third of people whose brains show the full pathology of Alzheimer's never develop dementia. Dutch researchers say the difference may not be how many young neurons they have, but whether those cells switch on a survival program instead of dying.

Brain & Aging

Alzheimer's Hitches a Ride on a Virus Your Neurons Tamed for Memory

In mice and in human Alzheimer's brains, toxic tau rides a protein called Arc, a virus your neurons domesticated for memory, from sick cells into healthy ones. Delete Arc and the spread nearly stops.

Brain & Aging

A Federally Backed Trial Got High-Dose Fish Oil Into the Brain Fluid. The Memory Scores Never Moved.

DHA in the spinal fluid climbed 17 percent. Cognitive scores rose 2.76 points on fish oil, 2.67 on placebo. Two years of high-dose pills bought a rounding error.

Brain & Aging

The Alzheimer's Field Spent Decades Trying to Destroy These Droplets. A Baylor Lab Says the Droplets Were Never the Problem.

A Baylor lab reports that tubulin redirects Tau and alpha-synuclein away from toxic clumping in the test tube. It is elegant mechanism work, and not yet a drug, an animal, or a person.

Brain & Aging

The Brain Was Starving Before the Plaques Showed Up: Alzheimer's Metabolic Reframe Has a Case, Not a Trial

A rising camp says failing mitochondria, not amyloid plaques, may drive Alzheimer's first. The biology is compelling and the amyloid monoculture earned its reckoning, but the metabolic side has its own retractions and not one human trial showing it works.

Brain & Aging

The amyloid-versus-tau war in Alzheimer's might be the wrong fight

A four-person UC Riverside chemistry group argues amyloid beta and tau compete for the same microtubule binding sites, a unifying mechanism that cuts under Alzheimer's research's three-decade amyloid-versus-tau fight.

Brain & Aging

Magic Mushrooms and an 80-Year-Old's Memory: What the Hype Actually Has, and What It Doesn't

An 80-something woman with advanced Alzheimer's took five grams of mushrooms and started speaking again. The biology behind why that might happen is real. The trial base it rests on is thinner than the headlines admit.

Brain & Aging

A molecule your body already makes coaxed exhausted brain cells back to fighting Alzheimer's

Spanish and Swiss researchers report that OLE, a fatty-acid amino-acid the body already makes, coaxed sluggish microglia to surround amyloid plaques and improve memory in Alzheimer's mice.